Testing dried blood spots to screen children for diabetes and celiac antibodies

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children aged 2-13 years who have type 1 diabetes or celiac disease, and children who have neither condition nor the related autoantibodies.

Age

2-13 years

Sex

All sexes can join.

Disease stage

Confirmed type 1 diabetes or celiac disease, or no type 1 diabetes, no celiac disease and no related autoantibodies.

Biomarker or test result

Children without the disease must not have autoantibodies linked to type 1 diabetes or celiac disease.

The registry criteria, word for word

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

• Are you between 2 and 13 years old?YesNo

What the trial wants to find out

Early diagnosis of type 1 diabetes and celiac disease is very useful, allows early therapy and prevents deaths from the onset of diabetic ketoacidosis. This is a pilot study on screening of autoantibodies of type 1 diabetes and celiac disease in tuscany patients. The study aims to evaluate the concordance between the screening results obtained using two different matrix (blood drop spots on card and serum) in the search for autoantibodies for celiac disease and for type 1 diabetes. Moreover, it will be evaluated the feasibility and acceptability of the screening on a sample of the population enrolled in the territory through the participation of pediatricians.

The 2 groups in the trial

• Test on blood sample (diagnosis of celiac and diabetes disease)Other group

  Treatment: Test on blood sample

• test on dried blood spot (celiac and diabetes patients)Other group

  Treatment: Test on dried blood sample